Yes l would imagine overseas buyers understand how important a phase 3 orphan drug will be, aussie investors not many, only the smart ones...
Ann: Neuren completes Phase 2 trial in pediatric Rett syndrome, page-26
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.07 |
Change
0.760(5.71%) |
Mkt cap ! $1.746B | |||
| Open | High | Low | Value | Volume |
| $13.50 | $14.21 | $12.96 | $7.036M | 509.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 546 | $14.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.08 | 99 | 2 |
View Market Depth
| Last trade - 15.07pm 27/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |